Congratulations Jimmy Gutman MD
Pfizer resumed development in July 2024 on a reformulated once-a-day pill
GLP-1 Basics GLP stands for glucagon-like peptide. This hormone is generated mostly in the intestines, and when its released, it has a series of effects on the body, including slowing down how quickly food moves through the stomach and reducing hunger levels
Drug Effectiveness and Market Positioning Evaluation: Reviews oral obesity drugs by analyzing weight loss performance, safety concerns, tolerability, cardiometabolic profile, drug regimen, patient suitability and competition with injectables
GLP-1 medications are renally cleared, meaning impaired kidney function prevents safe elimination from the body, leading to toxic accumulation
Also researchers should consider the legal implications of compound possession and use in their jurisdiction